Skip to content

Saturday, November 15, 2025

Latest:

Winning the race against time: How technology and policy have transformed pediatric heart transplant survival
In Memoriam: Bert W. O’Malley, M.D.
p53 mutant R273H opens new avenues for future personalized cancer treatment
Looking for something different to eat for Thanksgiving this year? Try going vegetarian.
Healthy Habits: Dr. Punam Amin’s kids motivate her to stay healthy

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

cisplatin

A new mechanism of cisplatin resistance in cancer, and how to reverse it

April 22, 2021 ACTL6A, cancer resistance to therapy, cisplatin, DNA repair, epigenetic chromatin remodeling, panobinostat, Research

ACLT6A overexpression confers cancer cells resistance to cisplatin, and researchers found a way to reverse it.

From the Labs: Image of the Month

From the Labs: Neurons in a Huntington’s brain

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951